HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

D3 peptide

Subscribe to New Research on D3 peptide

reduced Alzheimer's disease amyloid plaque load in transgenic mice

Also Known As:

D-enantiomeric amino acid peptide D3; RPRTRLHTHRNR; peptide D3

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins
- Peptides: 22950
  - Oligopeptides: 168
    - D3 peptide: 3

Experts

1.	Willbold, Dieter: 2 articles (01/2014 - 09/2010)
2.	Huhn, C: 1 article (09/2015)
3.	Funke, S A: 1 article (09/2015)
4.	Willbold, D: 1 article (09/2015)
5.	Willbold, S: 1 article (09/2015)
6.	Klein, Antonia N: 1 article (09/2015)
7.	Hänel, Karen: 1 article (09/2015)
8.	van der Burgt, Yuri E M: 1 article (09/2015)
9.	Pattky, Martin: 1 article (09/2015)
10.	Mohrlüder, Jeannine: 1 article (09/2015)

Related Diseases

1.

Alzheimer Disease (Alzheimer's Disease)

01/01/2014 - "In this study, we demonstrate that the small D-amino acid peptide D3, which was investigated for therapeutic studies on Alzheimer's disease (AD), significantly reduces both SEVI and Aβ fibril boosted infectivity of HIV-1. "
09/15/2010 - "Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic mice."
09/01/2015 - "This so-called peptide D3 was selected by mirror phage display against low molecular weight amyloid-β-peptide (Aβ) associated with Alzheimer's disease. "

Related Drugs and Biologics

1.	Amyloid (Amyloid Fibrils)